Registry of Toxic Effects of Chemical Substances (RTECS)
Manganese, monosulfate, monohydrate
RTECS #
OP0893500CAS #
10034-96-5Updated
September 201Molecular Weight
169.02Molecular Formula
O4S·Mn·H2OSynonyms
Manganese (II) sulfate monohydrateManganese sulfate monohydrate
Manganese(2+) sulfate monohydrate
Manganous sulfate monohydrate
Sulfuric acid, manganese(2+) salt (1:1), monohydrate
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
Cytogenetic Analysis | oral/mouse | 718 mg/kg/7D-continuous | MUREAV 240,159,1990 |
Cytogenetic Analysis | ovary/hamster | 180 mg/L | EMMUEG 10(Suppl 10),1,1987 |
gene conversion and mitotic recombination | /Saccharomyes cerevisiae | 40 µmol/L | MUREAV 137,47,1984 |
micronucleus test | oral/mouse | 205 mg/kg/24H-continuous | MUREAV 240,159,1990 |
mutation in microorganisms | /Saccharomyes cerevisiae | 40 µmol/L (-enzymatic activation step) | MUREAV 137,47,1984 |
sister chromatid exchange | ovary/hamster | 5 mg/L | EMMUEG 10(Suppl 10),1,1987 |
sperm morphology | oral/mouse | 513 mg/kg/5D-continuous | MUREAV 240,159,1990 |
Reproductive Effects Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/mouse | 513 mg/kg (5D male) | Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | MUREAV 240,159,1990 |
Tumorigenic Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/mouse | lowest published toxic dose: 1314 gm/kg/2Y- continuous | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Endocrine: Thyroid tumors | NTPTR* NTP-TR-428,1993 |
oral/mouse | lowest published toxic dose: 1297800 mg/kg/103W- continuous | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Endocrine: Thyroid tumors | NTIS** PB94-217148 |
oral/mouse | lowest published toxic dose: 1622250 mg/kg/103W- continuous | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Endocrine: Thyroid tumors | NTIS** PB94-217148 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
intravenous/mouse | lowest published toxic dose: 2 mg/kg | Liver: Other changes Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Metabolism (intermediary): Lipids including transport | TOLED5 148,41,2004 |
intravenous/mouse | lowest published toxic dose: 2 mg/kg | Liver: Other changes Biochemical: Metabolism (intermediary): Lipids including transport | TOLED5 148,41,2004 |
intravenous/rat | lowest published toxic dose: 4.5 mg/kg | Liver: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects | TOSCF2 73,378,2003 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/monkey | lowest published toxic concentration: 4.62 mg/m3/6H/65D- intermittent | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | TOSCF2 92,201,2006 |
inhalation/monkey | lowest published toxic concentration: 4.62 mg/m3/6H/33D- intermittent | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases | TOSCF2 92,201,2006 |
inhalation/monkey | lowest published toxic concentration: 4.62 mg/m3/6H/15D- intermittent | Blood: Other changes | TOSCF2 92,201,2006 |
inhalation/rat | lowest published toxic concentration: 0.5 mg/m3/45D- intermittent | Related to Chronic Data: Changes in testicular weight | TXAPA9 197,113,2004 |
inhalation/rat | lowest published toxic concentration: 0.1 mg/m3/90D- intermittent | Brain and Coverings: Changes in brain weight | TXAPA9 197,113,2004 |
inhalation/rat | lowest published toxic concentration: 0.478 mg/m3/13W- intermittent | Olfaction: Other olfaction effects Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation | INHTE5 16,481,2004 |
inhalation/rat | lowest published toxic concentration: 0.01 mg/m3/13W- intermittent | Brain and Coverings: Other degenerative changes | INHTE5 16,481,2004 |
oral/mouse | lowest published toxic dose: 546 gm/kg/13W- continuous | Liver: Changes in liver weight Blood: Pigmented or nucleated red blood cells Blood: Other changes | NTPTR* NTP-TR-428,1993 |
oral/rat | lowest published toxic dose: 42 gm/kg/14D- continuous | Liver: Changes in liver weight Blood: Changes in other cell count (unspecified) Blood: Changes in leukocyte (WBC) count | NTPTR* NTP-TR-428,1993 |
oral/rat | lowest published toxic dose: 28437 mg/kg/13W- continuous | Lung, Thorax, or Respiration: Changes in lung weight Blood: Changes in leukocyte (WBC) count Nutritional and Gross Metabolic: Weight loss or decreased weight gain | NTPTR* NTP-TR-428,1993 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 0.02 mg(Mn)/m3 (resp) | DTLVS* TLV/BEI,2013 |
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 0.1 mg(Mn)/m3 (inhal) | DTLVS* TLV/BEI,2013 |
TOXICOLOGY REVIEW | MUREAV 584,1,2005 | |
TOXICOLOGY REVIEW | MUREAV 721,27,2011 |
Standards and Regulations
Organization | Standard | Reference |
---|---|---|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
Occupational Exposure Limit-AUSTRALIA | time-weighted average 1 mg(Mn)/m3 (dust), JUL2008 | |
Occupational Exposure Limit-AUSTRALIA | time-weighted average 1 mg(Mn)/m3, short term exposure limit 3 mg(Mn)/m3 (fume), JUL2008 | |
Occupational Exposure Limit-BELGIUM | time-weighted average 0.2 mg(Mn)/m3, MAR2002 | |
Occupational Exposure Limit-DENMARK | time-weighted average 0.2 mg(Mn)/m3 (dust), MAY2011 | |
Occupational Exposure Limit-DENMARK | time-weighted average 0.2 mg(Mn)/m3 (fume), MAY2011 | |
Occupational Exposure Limit-FINLAND | time-weighted average 0.2 mg(Mn)/m3, inhal. dust, NOV2011 | |
Occupational Exposure Limit-FINLAND | time-weighted average 0.1 mg(Mn)/m3, resp. dust, NOV2011 | |
Occupational Exposure Limit-GERMANY | MAK 0.02 mg(Mn)/m3 (resp), 0.2 mg(Mn)/m3 (inhal), 2011 | |
Occupational Exposure Limit-HUNGARY | time-weighted average 5 mg(Mn)/m3, short term exposure limit 20 mg(Mn)/m3, SEP2000 | |
Occupational Exposure Limit-JAPAN | Occupational Exposure Limit 0.2 mg(Mn)/m3, MAY2012 | |
Occupational Exposure Limit-KOREA | time-weighted average 5 mg(Mn)/m3, 2006 | |
Occupational Exposure Limit-MEXICO | time-weighted average 0.2 mg(Mn)/m3;short term exposure limit 3 mg(Mn)/m3, 2004 | |
Occupational Exposure Limit-MEXICO | time-weighted average 1 mg(Mn)/m3 (fume), 2004 | |
Occupational Exposure Limit-NEW ZEALAND | time-weighted average 1 mg(Mn)/m3, JAN2002 | |
Occupational Exposure Limit-NORWAY | time-weighted average 2.5 mg(Mn)/m3, JAN1999 | |
Occupational Exposure Limit-POLAND | MAC(time-weighted average) 0.3 mg(Mn)/m3, MAC(C) 5 mg(Mn)/m3, JAN1999 | |
Occupational Exposure Limit-RUSSIA | time-weighted average 0.5 mg/m3, short term exposure limit 1.5 mg/m3, Skin, JUN2003 | |
Occupational Exposure Limit-SWEDEN | time-weighted average 0.2 mg(Mn)/m3, (total dust);time-weighted average 0.1 mg(Mn)/m3, (resp. dust), JUN2005 | |
Occupational Exposure Limit-SWITZERLAND | MAK-week 0.5 mg(Mn)/m3, inhal, JAN2011 | |
Occupational Exposure Limit-UNITED KINGDOM | time-weighted average 0.5 mg(Mn)/m3, OCT2007 | |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | ceiling concentration 5 mg(Mn)/m3 | CFRGBR 29,1926.55,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors) | ceiling concentration 5 mg(Mn)/m3 | CFRGBR 41,50-204.50,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry) | ceiling concentration 5 mg(Mn)/m3 | CFRGBR 29,1910.1000,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards) | ceiling concentration 5 mg(Mn)/m3 | CFRGBR 29,1915.1000,1993 |
NIOSH Documentation and Surveillance
Status in Federal Agencies
Organization | Reference |
---|---|
NCI Carcinogenesis Studies (feed);equivocal evidence:mouse | |
NCI Carcinogenesis Studies (feed);no evidence:rat |
- Page last reviewed:March 7, 2014
- Page last updated:February 6, 2017
- Content source:
- National Institute for Occupational Safety and Health (NIOSH) Education and Information Division